Park Ha Biological Tech

Park Ha Biological Technology experienced a sharp decline during regular trading, with the stock at $0.8541 as of ET 11:00, down 7.21% from the previous close of $0.9205, primarily driven by a combination of negative catalysts. The company announced partnerships with Amazon to enter the North American personal care market and with Cloud Factory for an AI-driven beauty platform, yet the stock continued to slide following a 41% after-hours surge, and the recent $2.0 million registered direct offering raises dilution concerns. Its Q4 2025 revenue fell 15.91% YoY to $642,823, while net loss widened 1154% to $2.26 million, with an EPS of -$3.54, highlighting deteriorating fundamentals. The current price sits 97.94% below the 52-week high of $41.49 but is up 402.12% year-to-date, and remains below its 20-day and 60-day moving averages of $1.306 and $1.208, reflecting weak technical positioning. However, after-hours trading saw a rebound to $0.9142, suggesting some short-term speculative interest.